Abdulmalik Saleh Alfawaz Altamimi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Abdulmalik Saleh Alfawaz Altamimi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Obaid Afzal
Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University
4 shared publications - Kamal Dua
NICM Health Research Institute and School of Science, Western Sydney University, Westmead, Sydney, Australia
3 shared publications - Waleed Hassan Almalki
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia
3 shared publications - Ahsas Goyal
Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India
2 shared publications - Gaurav Gupta
Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Punjab, India
2 shared publications - Imran Kazmi
Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2 shared publications
Latest Publications
- Open Access
- 3 January 2024
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 23, 34-52
Unraveling NEAT1's complex role in lung cancer biology
This review delves into the pivotal role of the long non-coding RNA NEAT1 in cancer biology, particularly in lung cancer (LC). It emphasizes NEAT1's unique subcellular localization and active involvement in gene regulation and chromatin remodeling. The review highlights NEAT1's impact on LC development and progression, including cell processes such as proliferation, migration, invasion, and resistance to therapy, positioning it as a potential diagnostic marker and therapeutic target. The complex web of NEAT1's regulatory interactions with proteins and microRNAs is explored, alongside challenges in targeting it therapeutically. The review concludes optimistically, suggesting future avenues for research and personalized LC therapies, shedding light on NEAT1's crucial role in LC.
- 3 January 2024
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 23, 34-52
Open AccessUnraveling NEAT1's complex role in lung cancer biology
This review delves into the pivotal role of the long non-coding RNA NEAT1 in cancer biology, particularly in lung cancer (LC). It emphasizes NEAT1's unique subcellular localization and active involvement in gene regulation and chromatin remodeling. The review highlights NEAT1's impact on LC development and progression, including cell processes such as proliferation, migration, invasion, and resistance to therapy, positioning it as a potential diagnostic marker and therapeutic target. The complex web of NEAT1's regulatory interactions with proteins and microRNAs is explored, alongside challenges in targeting it therapeutically. The review concludes optimistically, suggesting future avenues for research and personalized LC therapies, shedding light on NEAT1's crucial role in LC.
- 25 October 2023
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 15 (19) , 1807-1818
New Horizons in Lung Cancer Management Through ATR/CHK1 Pathway Modulation
Lung cancer is the leading cause of cancer-related deaths worldwide. Molecular profiling has contributed to a new classification of lung cancer, driving advancements in research and therapy. The at...
- 25 October 2023
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 15 (19) , 1807-1818
New Horizons in Lung Cancer Management Through ATR/CHK1 Pathway Modulation
Lung cancer is the leading cause of cancer-related deaths worldwide. Molecular profiling has contributed to a new classification of lung cancer, driving advancements in research and therapy. The at...
- 16 March 2023
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 82, 104368
Harnessing natural polysaccharides-based nanoparticles for oral delivery of phytochemicals: Knocking down the barriers
- 16 March 2023
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 82, 104368
Harnessing natural polysaccharides-based nanoparticles for oral delivery of phytochemicals: Knocking down the barriers
- 31 January 2023
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 81, 104196
Chitosan-based nano drug delivery system for lung cancer
- 31 January 2023
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 81, 104196
Chitosan-based nano drug delivery system for lung cancer